Latest Breaking News On - Anebulo pharmaceuticals doses more than half - Page 1 : comparemela.com

Anebulo Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse disorder , today. | April 1, 2022

United statesScott andersonSimon allenAnebulo pharmaceuticalsAnebulo pharmaceuticals incCompany or anebuloCentre for human drug researchSecurities exchangeAnebulo pharmaceuticals doses more than halfProvides guidanceHuman drug researchChief executive officerSecurities actSecurities exchange actAnebulo pharmaceuticalInvestor relations